Intrinsiqs

Is Chemed Corporation overvalued?

Chemed Corporation (CHE) looks overvalued — trading about 33% above its fair value.

Overvalued
Current price $548.20 Fair value $366.90
Price
$548.20
Fair value
$366.90
Current P/E
25.4
Normal P/E
17.0
Market cap
$7.13B
Dividend yield
0.5%
Return on equity
32.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CHE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.